Steven Cohen’s Roivant Sciences ROIV Stock Holding History

Steven Cohen’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Sell	6,600 -40,800	-86%	-$1.21M	﹤0.01%	3472
2026 Q1	$1.31M	Buy	47,400 +15,400	+48%	+$396K	﹤0.01%	2583
2025 Q4	$694K	Sell	32,000 -418,000	-93%	-$8.25M	﹤0.01%	3065
2025 Q3	$6.81M	Buy	+450,000	New	+$5.57M	0.01%	951

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Steven Cohen's ROIV Position: Q2 2026 in Review

Steven Cohen increased its Roivant Sciences (ROIV) stake by 402% in Q2 2026, buying an estimated $106M and bringing the position to 4,473,478 shares worth $158M. The position accounts for 0.17% of the portfolio, ranked #111.

Steven Cohen first reported a position in ROIV in Q2 2022 and has held it in 11 quarters since. 495 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Steven Cohen held 4,473,478 shares of Roivant Sciences worth $158M as of Q2 2026.
Steven Cohen bought 3,582,578 Roivant Sciences shares in Q2 2026, an estimated $106M.
Roivant Sciences made up 0.17% of Steven Cohen's portfolio in Q2 2026, its #111 holding.
Steven Cohen first reported a position in Roivant Sciences in Q2 2022 and has held it in 11 quarters since.
495 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.